Pylarify
Ended Awarded Last action
- Contract number
- 36C24124F0178
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 1
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $443,873
Award facts
- Contract value 100% obligated
- $443,872.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $346,437 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $97,435 |
About this award
This federal contract award to Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc., is for the delivery of PYLARIFY, a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect and image prostate cancer. The $443,872.56 firm fixed price delivery order contract was awarded by the Department of Veterans Affairs (VA) on August 16, 2024, and has a performance period ending on July 31, 2025. The contract is not set aside for small businesses and is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Lantheus Holdings, Inc. is the parent company of Progenics Pharmaceuticals and maintains several significant Indefinite Delivery Vehicles (IDVs) with the VA and Defense Health Agency for the procurement of radiopharmaceuticals, nuclear medicine supplies, and diagnostic imaging agents to support federal healthcare programs, particularly in the area of oncology imaging.
Quick answers
Who was awarded contract 36C24124F0178?
36C24124F0178 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 1 (Veterans Health Administration) on August 16, 2024.
How much is contract 36C24124F0178 worth?
The government has obligated $443,873 on 36C24124F0178.
Is contract 36C24124F0178 an order under another contract?
Yes. 36C24124F0178 is a delivery order under 36F79719D0170, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24124F0178 competed?
The extent of competition for 36C24124F0178 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award